USANA Health Sciences, Inc. (USNA): Price and Financial Metrics

USANA Health Sciences, Inc. (USNA)

Today's Latest Price: $85.91 USD

0.55 (0.64%)

Updated Jun 5 4:10pm

Add USNA to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 14 in Medical - Consumer Goods

See all "A" rated Strong Buy stocks

USNA Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for USNA is 3.32 -- better than 83.32% of US stocks.
  • For USNA, its debt to operating expenses ratio is greater than that reported by just 0.32% of US equities we're observing.
  • The volatility of Usana Health Sciences Inc's share price is greater than that of merely 14.73% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Usana Health Sciences Inc, a group of peers worth examining would be AAN, FET, CCCL, FAF, and DWSN.
  • USNA's SEC filings can be seen here. And to visit Usana Health Sciences Inc's official web site, go to
USNA Daily Price Range
USNA 52-Week Price Range

USNA Stock Price Chart More Charts

USNA Price/Volume Stats

Current price $85.91 52-week high $90.94
Prev. close $85.36 52-week low $43.01
Day low $85.85 Volume 121,670
Day high $87.79 Avg. volume 225,519
50-day MA $77.34 Dividend yield N/A
200-day MA $72.98 Market Cap 1.81B

USANA Health Sciences, Inc. (USNA) Company Bio

USANA Health Sciences develops and manufactures nutritional supplements, healthy foods and personal care products. The company was founded in 1992 and is based in Salt Lake City, Utah.

USNA Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

We started the process of determining a valid price forecast for Usana Health Sciences Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Usana Health Sciences Inc ranked in the 50th percentile in terms of potential gain offered. The most interesting components of our discounted cash flow analysis for Usana Health Sciences Inc ended up being:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 100. Its equity weight surpasses that of 99.34% of free cash flow generating stocks in the Consumer Defensive sector.
  • The business' balance sheet reveals debt to be 0% of the company's capital (with equity being the remaining amount). Approximately just 0% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • USNA's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 64.84% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Usana Health Sciences Inc? See DLTR, LW, BUD, NWL, and DL.

USNA Latest News Stream

Event/TimeNews Detail
Loading, please wait...

USNA Latest Social Stream

Loading social stream, please wait...

View Full USNA Social Stream

Latest USNA News From Around the Web

Below are the latest news stories about Usana Health Sciences Inc that investors may wish to consider to help them evaluate USNA as an investment opportunity.

USANA recognized as a best place to work and top revenue generator by leading industry publication

The direct selling industry is made up of hundreds of highly successful companies around the world. To be among the top as an employer and revenue generator is an impressive honor. USANA was recently named to both the Best Places to Work and the Global 100 lists from Direct Selling News® (DSN). It's the third time USANA has been recognized as one of the Best Places to Work, while also moving up two spots on the Global 100 list of top revenue generating direct sales companies—from number 18 to 16.

Yahoo | June 2, 2020

USANA Health Sciences, Inc. (NYSE:USNA) Is Employing Capital Very Effectively

Today we'll look at USANA Health Sciences, Inc. (NYSE:USNA) and reflect on its potential as an investment. To be...

Yahoo | May 26, 2020

Clinical study finds USANA's cognitive support supplement optimizes brain function after only one use

A new clinical study conducted by renowned brain health and cognitive performance expert Dr. Talitha Best of Central Queensland University has found that USANA® CopaPrime+ supports three cognitive measures—working memory and accuracy, attention speed and response time, and brain efficiency—only 45 minutes after participants took a single dose. The study was done in collaboration with Deakin University in Australia and Nanyang Technological University in Singapore.*

Yahoo | May 14, 2020

A Trio of High-Quality Stocks for the Value Investor

Their balance sheets are robust Continue reading...

Yahoo | May 6, 2020

USANA® Probiotic supplement earns seal of approval for the fifth time

USANA, a leader in cellular nutrition, is honored to receive another seal of approval from third-party tester This time for its USANA® Probiotic supplement. This marks the fifth time USANA's Probiotic has received the prestigious seal from

Yahoo | May 4, 2020

Read More 'USNA' Stories Here

USNA Price Returns

1-mo -0.91%
3-mo 16.05%
6-mo 13.02%
1-year 15.97%
3-year 32.27%
5-year 30.10%
YTD 9.37%
2019 -33.28%
2018 58.99%
2017 21.00%
2016 -4.19%
2015 24.52%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8264 seconds.